Related Experiment Video

Updated: Jun 16, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Impact of LDL-apheresis on inflammation and microcirculation

Michael J Koziolek1, Gerhard A Mueller

  • 1Department of Nephrology and Rheumatology, Georg-August-University Goettingen, Germany. mkoziolek@med.uni-goettingen.de

Atherosclerosis. Supplements
|February 5, 2010
PubMed

Insights

Lipid-apheresis (LIPID-A) significantly lowers harmful LDL cholesterol and lipoprotein (a), reducing cardiovascular events. It also improves vascular repair and blood flow by reducing inflammation and enhancing microcirculation.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Vascular Biology

Background:

  • Lipid-apheresis (LIPID-A) effectively reduces pro-atherosclerotic LDL-cholesterol and lipoprotein (a).
  • Previous studies show LIPID-A reduces major cardiovascular events.
  • LIPID-A offers benefits beyond lipid reduction, impacting inflammation and microcirculation.

Purpose of the Study:

  • To explore the pleiotropic effects of Lipid-apheresis.
  • To investigate LIPID-A's impact on inflammation, vascular repair, and microcirculation.

Main Methods:

  • Analysis of prospective and retrospective data on LIPID-A efficacy.
  • Assessment of inflammatory markers (cytokines, chemokines, adhesion molecules) cleared by LIPID-A.
  • Evaluation of LIPID-A's effect on endothelial progenitor cell proliferation.
  • Examination of LIPID-A's influence on microcirculatory parameters (mediator balance, viscosity, aggregation).

Main Results:

  • LIPID-A reduces LDL-cholesterol and lipoprotein (a), decreasing cardiovascular events.
  • Distinct LIPID-A methods clear pro-inflammatory mediators and adhesion molecules.
  • Single LIPID-A sessions stimulate endothelial progenitor cells, enhancing vascular repair.
  • LIPID-A improves microcirculation by modulating vasoactive mediators, reducing plasma viscosity and erythrocyte aggregation, thereby activating capillary reserve and blood flow.

Conclusions:

  • Lipid-apheresis is a potent therapy for reducing cardiovascular risk through lipid lowering and pleiotropic effects.
  • LIPID-A enhances vascular health by reducing inflammation, promoting repair, and improving microcirculation.
  • The multifaceted benefits of LIPID-A extend beyond lipid reduction, offering significant cardiovascular protection.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...